Reagents
Ended Awarded Last action
- Contract number
- W81K0023F0161
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $341,575
Award facts
- Contract value 100% obligated
- $341,575.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- FT LEONARD WD, MO 65473, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $113,563 | |
| Exercise an Option | $0 | |
| Funding Only Action | $228,012 | |
| Original award | $0 |
About this award
Roche Diagnostics Corporation received a firm fixed-price delivery order award from the Defense Health Agency on October 1, 2023, for reagents valued at $341,575.26, with performance at Fort Leonard Wood, Missouri, concluding March 31, 2025. This delivery order was issued without a set-aside designation and is a child contract under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, headquartered in Indianapolis and a foreign-owned manufacturer specializing in in vitro diagnostics and laboratory instruments, maintains an extensive federal contracting presence as a primary supplier of diagnostic technologies to Defense Health Agency and military healthcare systems.
The award represents Roche's continued supply of diagnostic reagents and consumables to the Defense Health Agency, consistent with the company's broader portfolio of diagnostic solutions supporting federal healthcare operations. Roche maintains multiple active indefinite delivery contracts and blanket purchase agreements with the Defense Health Agency, including contracts valued at up to $6.75 million for automated laboratory systems and $5.995 million for reagents and maintenance services, with many extending through 2028-2030. These agreements demonstrate sustained federal demand for Roche's advanced diagnostic capabilities across military and defense healthcare systems.
Quick answers
Who was awarded contract W81K0023F0161?
W81K0023F0161 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W81K0023F0161 worth?
The government has obligated $341,575 on W81K0023F0161.
Which agency awarded contract W81K0023F0161?
Medical Command (Department of the Army) awarded W81K0023F0161, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0023F0161 an order under another contract?
Yes. W81K0023F0161 is a delivery order under V797P7347A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract W81K0023F0161 competed?
The extent of competition for W81K0023F0161 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award